Despite its potential, there are significant challenges in the development of Nrf2-based therapies. The dual role of Nrf2 in both promoting cell survival and contributing to cancer progression complicates its therapeutic targeting. Additionally, the precise regulatory mechanisms of Nrf2 in various tissues and conditions remain an area of active research. Understanding these complexities is essential for the safe and effective use of Nrf2 modulators in clinical settings.
